A specific reversal agent for dabigatran is available: should you have it in your electrophysiology lab?
Topic:
Catheter ablation
Sponsored by Boehringer Ingelheim
Event:
ESC CONGRESS 2016
Presentation
About the speakers
Doctor Hugh Calkins
The Johns Hopkins Hospital, Baltimore (United States of America)
14
presentations
0
follower
Doctor Rajat Deo
Philadelphia (United States of America)
2
presentations
0
follower
Access the full session
About the event
Related content
ESC Premium Access
Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study
28 August 2021
This platform is supported by
